Clinical Studies on Reversibility of Pulmonary Airway Dysfunctions in Asymptomatic Smokers: Role of Nervous Mechanism in Small Airway Disease
Hiroshima Journal of Medical Sciences 34 巻 4 号
399-418 頁
1985-12 発行
アクセス数 : 272 件
ダウンロード数 : 43 件
今月のアクセス数 : 3 件
今月のダウンロード数 : 1 件
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00049883
ファイル情報(添付) |
HiroshimaJMedSci_34_399.pdf
2.41 MB
種類 :
全文
|
タイトル ( eng ) |
Clinical Studies on Reversibility of Pulmonary Airway Dysfunctions in Asymptomatic Smokers: Role of Nervous Mechanism in Small Airway Disease
|
作成者 |
Md. Masudur Rahman
|
収録物名 |
Hiroshima Journal of Medical Sciences
|
巻 | 34 |
号 | 4 |
開始ページ | 399 |
終了ページ | 418 |
収録物識別子 |
[PISSN] 0018-2052
[EISSN] 2433-7668
[NCID] AA00664312
|
抄録 |
Pulmonary function tests were performed on twenty eight males, among whom eight were healthy nonsmokers and twenty were asymptomatic smokers. Pulmonary function tests such as spirometry, respiratory impedance (Z3Hz), single breath nitrogen washout (SBN2) and volume of isoflow (VisoV) were done before and after inhalation of orciprenaline sulphate and atropine sulphate in all nonsmokers and smokers. Subdivisions of lung volume, diffusing capacity (DLco) and arterial blood gas analysis were conducted only before inhalation of drugs. Acute effects were studied after smoking a cigarette and effects of orciprenaline inhalation after smoking were also observed. Furthermore, effects of smoking on prior inhalation of orciprenaline, atropine or lidocaine were evaluated.
The results obtained were as follows: 1) There were no differences in the results of routine pulmonary function tests, between nonsmokers and smokers except Z3Hz, which was significantly higher in smokers (p<0.01) and there was a tendency to decrease in flow especially at low lung volumes in smokers. Smokers could be well differentiated from nonsmokers by VisoV/FVC (p<0.001) and the difference in distribution of ventilation was greater (p<0.05). 2) In nonsmokers, Z3Hz decreased and V50 increased significantly after inhalation of orciprenaline and atropine. FEV1.o increased significantly with atropine inhalation only. There were no changes in VisoV/FVC with inhalation of orciprenaline or atropine. In smokers, Z3Hz and VisoV/FVC decreased significantly after inhalation of orciprenaline or atropine (p<0.001). FEV1.o and flow rates improved significantly with both drugs. 3) After smoking a cigarette, Z3Hz and VisoV/FVC significantly increased (p < 0.01), but inhalation of orciprenaline or atropine prior to smoking significantly inhibited the acute effects of smoking and lidocaine completely inhibited the acute effects of smoking. These results indicate that several parameters such as Z3Hz, flow at low lung volume, VisoV/FVC could detect the airway dysfunctions in asymptomatic cigarette smokers. These airway dysfunctions might be due to increased vagal tone, leading to narrowing of the airways and these airway dysfunctions were reversible by bronchodilator drugs. |
著者キーワード |
Nonsmoker and smoker
Pulmonary function tests
Volume of isoflow
Reversibility of airway dysfunctions
Cholinergic nerve
|
内容記述 |
This study was performed in the Second Department of Internal Medicine, Hiroshima University School of Medicine, under a scholarship granted by The Ministry of Education, Science and Culture (Monbusho), The Government of Japan.
|
NDC分類 |
医学 [ 490 ]
|
言語 |
英語
|
資源タイプ | 紀要論文 |
出版者 |
Hiroshima University School of Medicine
|
発行日 | 1985-12 |
出版タイプ | Version of Record(出版社版。早期公開を含む) |
アクセス権 | オープンアクセス |
収録物識別子 |
[ISSN] 0018-2052
[NCID] AA00664312
[PMID] 3830997
|